Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating amlodipine for the treatment of endometrial cancer, with the study status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING